MedPath

LINEZOLID INJECTION

LINEZOLID INJECTION

Discontinued
DIN Number

02402637

Drug Class

Human

Market Date

Aug 18, 2014

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02402637
AIG Number0143501003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01XX08 LINEZOLID
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification08:12.28.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

LINEZOLIDActive
Strength: 2 MG / ML
Monograph: LINEZOLID

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.